Johnson & Johnson’s Abiomed has sent an urgent medical device correction about a malfunction risk linked to 22 reports of ...
The FDA has issued an early alert warning of a potentially high-risk issue affecting certain Abiomed heart pumps. The agency said Abiomed issued an urgent medical device correction Jan. 27 for all ...
The Food and Drug Administration Feb. 3 released an early alert on a heart pump issue from certain Abiomed products.
The FDA issued an early alert related to updated instructions for certain Impella devices from Johnson & Johnson MedTech’s ...
The agency says there have been 22 injuries and no deaths associated with this potentially high-risk device issue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results